David McNally, CEO of Titan Medical, a medical device company that is focused on enhancing robotic single access surgery, discusses the development of a single-port robotic surgical system called Enos™, and the many benefits it can provide to patients, hospitals, and surgeons. Titan Medical recognized the need for single incision surgery from clinical input from surgeons performing both manual and robotic laparoscopic surgeries. The Enos system is initially being investigated for use in hysterectomies. The Enos system has not been cleared by any regulatory authority and is not available commercially.
Author: healthprofessionalradio
New Data Supports Effectiveness of Cell-Based and Adjuvant Influenza Vaccines
Returning guest, Dr. Gregg Sylvester, MD, Chief Medical Officer at Seqirus, one of the world’s largest influenza vaccine providers discusses some new real-world evidence that was presented at the global International Society for Influenza and other Respiratory Virus Diseases (ISIRV) – World Health Organization (WHO) Virtual Conference that showed that cell-based quadrivalent seasonal influenza (QIVc) vaccines were more effective in children and adults and adjuvanted trivalent seasonal influenza vaccines (aTIV) were more effective in older populations.
MorphImmune – Could Cellular Reprogramming Be the Next Innovation in Cancer and Fibrosis?
Ronald Martell, President and CEO at MorphImmune discusses MorphImmune’s proprietary platform that enables reprogramming or removal of aberrant cells with targeted effector molecules linked to precision small molecules and is further designed to enable the creation of countless combinations of targeted molecules to treat a wide variety of diseases effectively and safely. The company’s discovery platform has enabled the identification of 10+ additional targets for consideration.
From Pain to Purpose – Minimizing Opioid Use in Women’s Health
Dr. Angela Stoehr, OB/GYN, addresses how the pandemic exacerbated the opioid epidemic and the need to refocus on non-opioid pain management approaches after surgery across several procedures especially in women’s health.
CareDx – ACROBAT Study for Stem Cell Transplant Patients
Dr. Sham Dholakia, MD, Chief Medical Officer at CareDx, a company focused on high-value healthcare solutions for transplant patients, discusses the Assessing Chimerism and Relapse of Bone marrow/HCT transplant using AlloHeme Testing (ACROBAT) study at the Cleveland Clinic in Ohio.
Inequalities in Dental Care Inspire SprintRay CEO to Revolutionize 3D Dental Technology
Amir Mansouri, PhD, CEO and Co-Founder of SprintRay, discusses how his vision to revolutionize the dental industry with new “on-demand” 3D printing technology, which will be released in early 2022, inspired him and his company to address dental access inequality globally. In fact, SprintRay will soon announce an exciting partnership to launch a charitable initiative to provide underserved global populations with high-quality dental care.
Lung Cancer Awareness – Ambulatory Precision Lung Sparing (A-PLUS) Surgery Program
Dr. Samuel Kim, a thoracic surgeon at Northwestern Medicine discusses the Ambulatory Precision Lung Sparing (A-PLUS) surgery program born from the need to be able to screen and treat patients for lung cancer during the pandemic. The doctors at Northwestern Medicine spent the past several years honing this highly precise, minimally invasive, lung-conserving, robot-guided outpatient surgery where the patient can be released the same day.
HeartFlow – New Imaging Tools in Cardiology Diagnostics
Dr. Campbell Rogers, Executive Vice President and Chief Medical Officer at HeartFlow discusses some of the latest developments in cardiovascular care, including HeartFlow’s technology, which leverages artificial intelligence to create a personalized 3D model of a patient’s heart to help physicians diagnose heart disease, the leading cause of death in the world.
The Impact of COVID-19 on Immunocompromised Patients
Dr. Brian Koffman, Executive Vice President and Chief Medical Officer, CLL (chronic lymphocytic leukemia) Society and a CLL patient discusses the impact and burden of COVID on immunocompromised patients, who may not be able to mount the proper immune response to build antibodies needed to fight against the virus. He also talks about need for preventative options beyond vaccines.
ACR 2021 – Horizon’s Data on Unconscious Bias’s Impact on Uncontrolled Gout Patient Outcomes
Returning guest, Dr. Larry Edwards, Professor of Medicine, Division of Rheumatology and Clinical Immunology, and Program Director and Vice Chairman of the Department of Medicine at the University of Florida in Gainesville discusses a presentation from the American College of Rheumatology (ACR) Convergence 2021 Virtual Annual Meeting titled “Gout Stigma: Investigating the existence of gout stigma and its impact on patient perceptions and treatment decisions” (Abstract 0680)